Changes in serum levels of metalloproteinases and their inhibitors by treatment of chronic hepatitis C with interferon (Q71068620)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8625775%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

title

Changes in serum levels of metalloproteinases and their inhibitors by treatment of chronic hepatitis C with interferon (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8625775%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference

1 reference

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8625775%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

author name string

M Arai

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8625775%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

M Niioka

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8625775%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

K Maruyama

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8625775%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

N Wada

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8625775%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

N Fujimoto

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8625775%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

T Nomiyama

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8625775%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

S Tanaka

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8625775%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

publication date

1 May 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8625775%20AND%20SRC:MED&resulttype=core&format=json

Digestive Diseases and Sciences

15 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8625775%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8625775%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8625775%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

page(s)

995-1000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8625775%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf02091543

15 October 2019

exact match

0 references

cites work

Fibrogenic cytokines: the role of immune mediators in the development of scar tissue

1 reference

12 December 2020

Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor

1 reference

12 December 2020

Lymphoblastoid alpha-interferon for chronic hepatitis C: a randomized controlled study

1 reference

12 December 2020

Gamma-interferon treatment inhibits collagen deposition in murine schistosomiasis.

1 reference

12 December 2020

Non-A, non-B hepatitis: advances and unfulfilled expectations of the first decade

1 reference

12 December 2020

Direct measurement of neutral collagenase activity in homogenates from baboon and human liver

1 reference

12 December 2020

Differential regulation of glycosaminoglycan, fibronectin, and collagenase production in cultured human dermal fibroblasts by interferon-alpha, -beta, and -gamma

1 reference

12 December 2020

Interferon-gamma reverses the stimulation of collagen but not fibronectin gene expression by transforming growth factor-beta in normal human fibroblasts

1 reference

12 December 2020

alpha-Interferon in the treatment of chronic viral hepatitis: effects on fibrogenesis serum markers

1 reference

12 December 2020

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

12 December 2020

Comparative study of clinical, histological, and immunological responses to interferon therapy in type non-A, non-B, and type B chronic hepatitis

1 reference

12 December 2020

Tumor necrosis factor bifunctionally regulates matrix metalloproteinases and tissue inhibitor of metalloproteinases (TIMP) production by human fibroblasts

1 reference

12 December 2020

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

12 December 2020

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

12 December 2020

A one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases-2 using monoclonal antibodies

1 reference

12 December 2020

A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 1 (interstitial collagenase) using monoclonal antibodies

1 reference

12 December 2020

Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. An application for rheumatoid arthritis serum and plasma

1 reference

12 December 2020

A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 3 (stromelysin-1) using monoclonal antibodies.

1 reference

12 December 2020

Selective inhibition of human diploid fibroblast collagen synthesis by interferons

1 reference

12 December 2020

One step sandwich enzyme immunoassay for human type IV collagen using monoclonal antibodies

1 reference

12 December 2020

A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies

1 reference

12 December 2020

Collagenase activity in experimental hepatic fibrosis

1 reference

12 December 2020

Histological changes of the liver by treatment of chronic non-A, non-B hepatitis with recombinant leukocyte interferon alpha. Comparison with histological changes in chronic hepatitis B.

1 reference

12 December 2020

Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy

1 reference

12 December 2020

Interferon-alpha 2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: a quantitative histological evaluation

1 reference

12 December 2020

Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis.

1 reference

12 December 2020

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis

1 reference

12 December 2020

The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells

1 reference

12 December 2020

Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report

1 reference

12 December 2020

Mammalian collagenase increases in early alcoholic liver disease and decreases with cirrhosis

1 reference

12 December 2020

Hepatic fibrosis--current concepts of pathogenesis and therapy

1 reference

12 December 2020

Collagenase production by rabbit liver cells in monolayer culture

1 reference

12 December 2020

Decrease in serum levels of markers of hepatic connective tissue turnover during and after treatment of chronic hepatitis B with interferon-alpha

1 reference

12 December 2020

Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro

1 reference

12 December 2020

One-step sandwich enzyme immunoassay for human laminin using monoclonal antibodies

1 reference

12 December 2020

Gene expression of interstitial collagenase (matrix metalloproteinase 1) in gastrointestinal tract cancers

1 reference

12 December 2020

A randomized controlled open study of interferon alpha-2b treatment of chronic non-A, non-B posttransfusion hepatitis: no correlation of outcome to presence of hepatitis C virus antibodies

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02091543

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8625775%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference